Long-term safety of biologic and targeted synthetic disease modifying drugs in rheumatology. Barth K, Gill H, Singh N. Curr Opin Rheumatol 2024;36:113-119.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Barth K, Gill H, Singh N. Long-term safety of biologic and targeted synthetic disease modifying drugs in rheumatology. Curr Opin Rheumatol 2024;36:113-119.
PMID: 38126228